Industrial Scale Suspension Culture of Living Cells

The History and Economic Relevance of Industrial Scale Suspension Culture of Living Cells (Hans-Peter Meyer, Diego R. Schmidhalter)PART I: SUSPENSION CULTURE OF BACTERIA, YEASTS, AND FILAMENTOUS FUNGIBacterial Suspension Cultures (Patrick Sagmeister, Mohammad Jazini, Joachim Klein, and Christoph Herwig)Yeast Suspension Culture (Diethard Mattanovich, Carmen Jungo, Jana Wenger, Michal Dabros, and Michael Maurer)Filamentous Fungi Fermentation (Anders Norregaard, Stuart M. Stocks, Mads O. Albaek, John M. Woodley, and Krist V. Gernaey)PART II: SUSPENSION CULTURE OF ALGAE AND PLANT CELLSMicroalgae Grown Under Heterotrophic and Mixotrophic Conditions (Karin Kovar, Pavel Pribyl, and Markus Wyss)Recombinant Protein Production with Microalgae (Alexandre Lejeune, Rémy Michel, and Aude Carlier)Suspension Culture of Microorganisms (Algae and Cyanobacteria)under Phototrophic Conditions (Peter Bergmann, Astrid Nissen, Lars Beyer, Peter Ripplinger, Walter Trösch)Suspension Culture of Plant Cellsunder Heterotrophic Conditions (Nicole Imseng, Stefan Schillberg, Cornelia Schürch, Daniel Schmid, Kai Schütte, Gilbert Gorr, Dieter Eibl, and Regine Eibl)Suspension Culture of Plant Cells under Phototrophic Conditions (Holger Niederkrüger, Paulina Dabrowska-Schlepp, and Andreas Schaaf)PART III: SUSPENSION CULTURE OF PROTOZOA, INSECT CELLS, AVIAN CELLS, AND MAMMALIAN CELLSSuspension Culture of Protozoan Organisms (M.W.W. Hartmann and R. Breitling)Industrial Large Scale of Suspension Culture of Insect Cells (António Roldão, Manon Cox, Paula Alves, Manuel Carrondo, and Tiago Vicente)Avian Suspension Culture Cell Lines for Production of Vaccines and Other Biologicals (Manfred Reiter, Daniel Portsmouth, and P. Noel Barrett)Large Scale Suspension Culture of Mammalian Cells (Richard M Alldread, John R. Birch, Hilary K Metcalfe, Suzanne Farid, Andrew J. Racher, Robert J. Young, and Mohsan Khan)PART IV: SUSPENSION CULTURE FOR SPECIAL PRODUCTSPillars of Regenerative Medicine: Therapeutic Human Cells

The holder of a PhD in microbiology from the University of Fribourg, Switzerland, Hans-Peter Meyer served as VP Strategic Projects Biotechnology at Lonza until his retirement in early 2014. Following three years of postdoctoral studies in Stockholm, at the University of Pennsylvania, Philadelphia, and Lehigh University, Bethlehem, USA, in 1982 he joined Prof. Armin Fiechter's team as group leader at the ETH in Zürich before starting at Lonza in Visp, Switzerland in 1986, where he held a number of positions in R&D, manufacturing, and sales & marketing. He recently joined the faculty of the University of Applied Sciences and Arts of Western Switzerland, and also remains an expert at the Commission for Technology & Innovation (CTI) of the Swiss Federal Confederation.Diego R. Schmidhalter is head of R&T within the pharma and biotechnology custom manufacturing division at Lonza Switzerland. He holds a PhD in microbiology from the University of Fribourg, Switzerland, and carried out two years of postdoctoral studies at Genencor International, California, USA. He has held various management positions at Lonza, including head of microbial anufacturing, head of the Biopharma R&D Services business, and as head of Microbial Manufacturing Science and Technology, as well as being a member of the Biopharmaceuticals business team. Dr. Schmidhalter has over 20 years of experience in the biotechnology industry in biopharmaceuticals and biochemicals process development and manufacturing, technology transfer, scaling-up fermentations right up to the 50,000-liter scale, and within the biopharmaceuticals related regulatory environment.